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Abstract
During a lytic gammaherpesvirus infection, host gene expression is severely restricted by the global degradation and altered
39 end processing of mRNA. This host shutoff phenotype is orchestrated by the viral SOX protein, yet its functional
significance to the viral lifecycle has not been elucidated, in part due to the multifunctional nature of SOX. Using an
unbiased mutagenesis screen of the murine gammaherpesvirus 68 (MHV68) SOX homolog, we isolated a single amino acid
point mutant that is selectively defective in host shutoff activity. Incorporation of this mutation into MHV68 yielded a virus
with significantly reduced capacity for mRNA turnover. Unexpectedly, the MHV68 mutant showed little defect during the
acute replication phase in the mouse lung. Instead, the virus exhibited attenuation at later stages of in vivo infections
suggestive of defects in both trafficking and latency establishment. Specifically, mice intranasally infected with the host
shutoff mutant accumulated to lower levels at 10 days post infection in the lymph nodes, failed to develop splenomegaly,
and exhibited reduced viral DNA levels and a lower frequency of latently infected splenocytes. Decreased latency
establishment was also observed upon infection via the intraperitoneal route. These results highlight for the first time the
importance of global mRNA degradation during a gammaherpesvirus infection and link an exclusively lytic phenomenon
with downstream latency establishment.
Citation: Richner JM, Clyde K, Pezda AC, Cheng BYH, Wang T, et al. (2011) Global mRNA Degradation during Lytic Gammaherpesvirus Infection Contributes to
Establishment of Viral Latency. PLoS Pathog 7(7): e1002150. doi:10.1371/journal.ppat.1002150
Editor: Samuel H. Speck, Emory University, United States of America
Received November 9, 2010; Accepted May 20, 2011; Published July 21, 2011
Copyright:  2011 Richner et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This research was supported by NIH grants K01-CA117982 and R01-CA136367 to B.G. and a University of California Berkeley Cancer Research
Coordinating Committee (CRCC) Fellowship to J.R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the
manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: glaunsinger@berkeley.edu
Introduction
A number of viruses from diverse evolutionary lineages down-
regulate cellular gene expression through a variety of mechanisms
[1,2,3,4]. For certain viruses this host shutoff activity is a
consequence of viral gene expression strategies, such as influenza-
virus cap snatching [5] or picornavirus translation factor cleavage
to facilitate alternate mechanisms of ribosome engagement [6].
For others, the contribution of host shutoff towards viral
replication and gene expression is not as apparent, although
proposed roles include resource reallocation and immune evasion
[6,7]. In many cases, the precise in vivo function has been difficult
to delineate, in part due to the multifunctional nature of the viral
proteins driving host shutoff and the lack of appropriate model
systems. Within this latter category are the gammaherpesviruses,
which direct host shutoff primarily through the induction of host
mRNA degradation.
Gammaherpesviruses include the human pathogens Epstein-
Barr virus (EBV/HHV-4) and Kaposi’s sarcoma-associated
herpesvirus (KSHV/HHV-8) [8], the etiologic agents of some of
the most common AIDS-associated cancers, such as Burkitt’s
lymphoma, nasopharyngeal carcinoma, and primary effusion
lymphoma. The related murine gammaherpesvirus 68 (MHV68)
is often used as a model for human gammaherpesviruses because,
unlike KSHV and EBV, it is genetically tractable, readily
replicates in tissue culture without the use of chemicals or
overexpression to overcome latency, and infects small rodents
including laboratory mice [9,10,11]. MHV68 has therefore been
instrumental in the identification of factors that contribute to in vivo
replication and pathogenesis of the gammaherpesviruses.
All herpesviruses exhibit a biphasic lifecycle. In the latent state
few viral genes are expressed, and the viral genome is maintained
in the nucleus of the host cell until stimulating signals induce lytic
reactivation [12,13,14]. Most gammaherpesvirus-induced diseases
are associated with latency. During the lytic cycle the vast majority
of viral genes are expressed, and the virus undergoes active
replication to produce progeny virions. At this stage during
productive replication, gammaherpesviruses induce global mRNA
degradation via the product of the alkaline exonuclease gene,
termed SOX in KSHV, muSOX (ORF37) in MHV68, and
BGLF5 in EBV [1,15,16]. SOX and its homologs are conserved in
all subfamilies of herpesviruses, where they were first identified as
DNA exonucleases critical for the resolution of branched
structures that arise during viral DNA replication [17,18,19,20].
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SOX protein have an additional mRNA turnover function.
Although the precise mechanism by which these proteins cause
mRNA degradation remains unclear, biochemical evidence
suggests that at least EBV BGLF5 and KSHV SOX possess some
intrinsic ribonuclease (RNase) activity in vitro [21,22]. In addition
to mRNA turnover, SOX promotes the nuclear relocalization of
cytoplasmic poly(A) binding protein (PABPC), which leads to
aberrant polyadenylation and nuclear retention of mRNAs
[23,24]. The failure to repopulate the cytoplasm with newly
transcribed mRNAs is thought to increase the overall magnitude
of the host gene expression blockade [23].
The contribution of host shutoff towards the gammaherpesviral
lifecycle is unknown, and efforts to delete muSOX from MHV68
yielded virus unable to replicate, presumably due to an essential
role for the DNase activity [16]. Previous studies found the DNase
and host shutoff functions of SOX and BGLF5 to be genetically
separable [25,26], making it possible to evaluate the role of each
function of the protein in isolation. We report herein the
identification of a functionally similar MHV68 muSOX point
mutant that renders the virus selectively defective for host shutoff,
enabling the analysis of the role of this phenotype during infection
of cultured cells and in vivo. The mutant virus exhibited little to no
defect during multi-step growth curves in tissue culture or during
acute replication in the mouse lung following intranasal inocula-
tion. Unexpectedly, the virus accumulated to significantly reduced
levels in the lymph nodes at 10 days post infection and was highly
attenuated at the downstream stage of latency establishment. Once
trafficking was bypassed via an intraperitoneal infection, the host
shutoff defective virus still was attenuated in establishing latency in
the spleen. Our results identify for the first time a key role for the
lytic mRNA turnover activity in establishing viral latency,
emphasizing the important interplay between these seemingly
disparate stages of the viral lifecycle.
Results
Identification of a Host Shutoff Defective muSOX Mutant
We sought to evaluate the contribution of muSOX-induced
mRNA turnover towards the gammaherpesvirus lifecycle through
the generation of a muSOX mutant lacking mRNA turnover
activity but retaining the conserved DNase function. We
engineered mutations in the sites necessary for host shutoff activity
in muSOX homologs from other gammaherpesviruses (EBV
BGLF5 [25] and KSHV SOX [26]), as well as in several sites
selectively conserved amongst these homologs that lay outside the
putative DNase domains [27]. However, none of the mutants
generated had the desired single-function phenotype (Table S1).
We therefore designed an unbiased screen to investigate a large
number of mutants following the previous methodology used to
identify the single-function SOX variants (Figure 1A) [26]. Briefly,
the muSOX gene was amplified by error-prone PCR under
conditions designed to introduce 1–4 mutations per gene. The
PCR product was then cloned into a mammalian expression
vector, and clones were screened for the ability to repress
expression of a GFP reporter in a fluorescence-based assay in
293T cells. Mutants that did not deplete GFP fluorescence were
categorized as host shutoff defective and further analyzed for wild-
type protein expression levels by Western blotting, as even minor
changes to the muSOX primary amino acid sequence often
significantly reduced its protein expression. Finally, candidate
mutants were tested for retention of DNase activity using an in vitro
assay established previously for SOX and BGLF5 [25,26]. After
screening approximately 150 candidates, we identified a clone that
lacked mRNA degradation activity of the GFP reporter, but
retained wild-type protein expression levels and DNase activity.
Sequencing revealed this clone to have only a single non-silent
mutation, the amino acid substitution R443M, which we modified
to R443I for purposes of screening by restriction digest. MuSOX
R443I failed to suppress GFP protein expression in the
fluorescent-based assay for host shutoff (Figure 1B), which was a
consequence of its inability to degrade GFP mRNA (Figure 1C).
R443I is expressed at slightly higher levels than wild-type (WT)
muSOX (Figure 1D), as expected of a mutant that cannot promote
turnover of its own mRNA. Importantly, WT and R443I muSOX
both degrade linear DNA with very similar kinetics (Figure 1E).
We conclude that the amino acid substitution R443I produces a
single-function muSOX mutant selectively defective for host
shutoff activity.
Generation and in vitro Characterization of MHV68.DHS
To investigate the role of muSOX-induced host shutoff during
viral infection, we engineered a host shutoff defective MHV68
virus by replacing WT muSOX with muSOX R443I using
bacterial artificial chromosome (BAC)-based homologous recom-
bination [28]. The R443I mutation introduced an additional PsiI
restriction site within the muSOX gene, allowing us to screen for
successful recombination via restriction digest (Figure 2A). We also
generated a mutant rescue (MR) virus by replacing the R443I
mutant with WT muSOX to ensure that any observed phenotypes
could be attributed to the R443I mutation rather than to
unexpected secondary mutations elsewhere in the viral genome.
Restriction digests with PsiI and EcoRI confirmed that both
recombinant viruses were successfully isolated and did not have
any unexpected recombination events (Figures 2B & 2C). These
viruses shall henceforth be referred to as MHV68.DHS (host
shutoff defective virus) and MHV68.MR (mutant rescue virus).
Sequencing of muSOX and the surrounding genomic regions in
both recombinants confirmed that only the desired changes were
introduced.
We next verified that the R443I mutation in MHV68.DHS
conferred a host shutoff defect during viral infection. We assayed
levels of several endogenous mRNAs by real-time quantitative PCR
(RT-qPCR) following infection of NIH 3T3 fibroblasts with wild-
type MHV68 (MHV68.WT), MHV68.DHS, or MHV68.MR. WT
Author Summary
Herpesviruses are ubiquitous pathogens infecting a wide
range of hosts. They exhibit a biphasic lifecycle comprised
of a lytic replicative stage and a relatively dormant latent
stage. Members of the gammaherpesvirus subfamily
include the human pathogens Epstein-Barr virus and
Kaposi’s sarcoma-associated herpesvirus, the etiologic
agents of some of the most common AIDS-associated
malignancies. During a lytic gammaherpesvirus infection,
cellular gene expression is severely compromised in a
process termed host shutoff. In this study, we address the
purpose of this activity in the viral lifecycle through the
generation of a single amino acid point mutant selectively
defective for host shutoff activity. Unexpectedly, host
shutoff appears largely dispensable for viral replication, yet
plays an important role in the ability of the virus to traffic
and establish latency in the host organism. These findings
link two distinct phases of the viral lifecycle and indicate
that the global manipulation of gene expression may
contribute to the establishment of a lifelong gammaher-
pesvirus infection.
Role of RNA Turnover in Gammaherpesvirus Infection
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(tubb5), rplp2, and gapdh mRNA levels to 20–40% of the mock
infected sample. In contrast, mRNA levels remained significantly
higher in MHV68.DHS infected cells (Figure 3A–3D). Thus, the
single amino acid change R443I in muSOX is sufficient to suppress
virus-induced endogenous mRNA turnover. The somewhat lower
endogenous mRNA levels in MHV68.DHS compared to mock
infected cells could be due either to incomplete inactivation of the
muSOX host shutoff function, or to the contribution of one or more
additional viral genes towards host shutoff.
An additional phenotype linked to host shutoff caused by muSOX
and its homologs is the relocalization of cytoplasmic poly(A) binding
protein (PABPC) into the nuclei of infected cells [24]. We observed
clear nuclear relocalization of PABPC in cells infected with
MHV68.WT, whereas in mock infected or cells infected with
MHV68.DHS, PABPC remained cytoplasmic (Figure 3E). Thus,
Figure 1. Isolation of the single-function muSOX mutant R443I. (A) Diagram of the random PCR mutagenesis screening strategy. (B) HEK293T
cells were transfected with a plasmid expressing GFP alone or together with a plasmid expressing HA-tagged wild-type (wt) muSOX or muSOX R443I.
GFP fluorescence was monitored 24 h post transfection, along with HA-muSOX, which was detected by immunofluorescence with anti-HA
antibodies. Samples were co-stained with DAPI to visualize nuclei. (C) Cells were transfected for 24 h as described above, whereupon GFP mRNA and
18S rRNA levels were analyzed by Northern blot. Shown is a representative northern blot for GFP mRNA and 18S rRNA, and below is the normalized
data from five independent experiments with means and standard deviations shown. (D) Total protein was harvested 24 h post transfection with the
indicated plasmids, and Western blotted with anti-HA antibodies. The bottom band present in all samples is due to non-specific binding of the
antibody. (E) In vitro translated GFP, wild-type muSOX, or muSOX-R443I was incubated with linear DNA for the indicated times. DNA was then
extracted and separated by agarose gel electrophoresis. A representative figure from three independent experiments is shown.
doi:10.1371/journal.ppat.1002150.g001
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depletion and PABPC relocalization. These results also demonstrate
for the first time that muSOX-induced host shutoff is necessary to
drive PABPC relocalization during a viral infection.
Previous studies with MHV68 mutants have shown that muSOX
is critical for replication in cultured cells [16,19]. To determine the
contribution of host shutoff activity towards this defect, we
performed a multi-step growth curve in murine fibroblasts. 3T3
cells were infected at a multiplicity of infection (MOI) of 0.1 plaque
forming units (pfu) per cell and MHV68.WT, MHV68.DHS, and
MHV68.MR all replicated to equivalent titers and with similar
kinetics (Figure 4). We sequenced the muSOX gene from
MHV68.DHS samples at 5 days post-infection (dpi) and found no
evidence for reversion or secondary mutations (data not shown).
Therefore, muSOX-dependent mRNA degradation had little effect
on viral titers in 3T3 cells through multiple replication cycles.
MHV68.DHS Causes Larger Plaques to Develop and
Increased Expression of Lytic Cycle Proteins
Interestingly, we noticed that plaques derived from
MHV68.DHS infections differed morphologically from those
obtained upon MHV68.WT or MHV68.MR infections
(Figure 5A). To quantify these differences, we measured 75
plaques from 5 independent MHV68.DHS and MHV68.MR
infections and found that, indeed, MHV68.DHS plaques were
generally larger (p-value ,0.01) and had a broader frequency
distribution (Figure 5B). This seemed unlikely to be a consequence
of more rapid lytic replication, given the above growth curve
results. In addition, the altered plaque size does not appear to be
caused by enhanced cell-to-cell spread of the mutant virus, as we
observed no significant differences in the ratio of extracellular to
intracellular virus produced in 3T3 cells infected with
MHV68.WT, MHV68.DHS, and MHV68.MR (data not shown).
We and others have consistently observed that plaques formed
upon infection with wild-type (or mutant rescue) MHV68 are often
quite heterogeneous in size. One possible explanation for this is
asynchronous entry into the lytic cycle, in which smaller plaques
arise from later entry into the lytic cycle. In this regard, we sought
to determine whether the large plaque phenotype of MHV68.DHS
might be due to enhanced entry into the lytic cycle, signified by an
increased percentage of infected cells expressing early lytic proteins
relative to the wild-type virus. To test this hypothesis, we acquired
a version of MHV68 (MHV68-YFP) which constitutively expresses
YFP from a CMV promoter, regardless of whether infected cells
Figure 2. Generation of the MHV68.DHS virus. (A) Outline of the strategy for generating MHV68-muSOX-R443I (MHV68.DHS), in which the
muSOX amino acid arginine at position 443 was mutated to isoleucine, creating an additional PsiI site. The number is derived from the sequenced
MHV68 genome [10] (Refseq: NC_001826). (B) MHV68.WT, MHV68.DHS, and MHV68.MR BAC DNA were digested with the enzyme PsiI and
subsequently resolved on an agarose gel to confirm successful generation of the desired mutants. Arrows indicate the new 1200 bp and 450 bp
bands generated after introduction of the PsiI restriction site in muSOX R443I. (C) MHV68.WT, MHV68.DHS, and MHV68.MR BAC DNA were digested
with the enzyme EcoRI and subsequently resolved on an agarose gel to confirm no unexpected recombination had occurred.
doi:10.1371/journal.ppat.1002150.g002
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a general marker of infection, whereas lytically infected cells are
identified by immunofluorescence-based detection of the early lytic
protein muSOX. NIH 3T3 cells were infected at an MOI of 1 with
either MHV68-YFP or a version of MHV68-YFP bearing the
muSOX R443I mutation (MHV68-YFP.DHS), and the percent-
age of cells co-expressing muSOX and YFP was calculated at
18 hours post infection. A similar number of YFP-expressing cells
were detected in cultures infected with MHV68-YFP and
MHV68-YFP.DHS, indicating equivalent efficiency of initial
infection (Figure 5C & data not shown). However, there was an
approximately three-fold increase in the percent of cells co-
expressing both YFP and muSOX following infection with
MHV68-YFP.DHS compared to MHV68-YFP (30.1% versus
11.0%; Figure 5C). A similar trend was observed when the YFP-
and muSOX-expressing cell populations were analyzed by flow
cytometry following infection with these viruses (Figure S1). Also
in agreement with these findings were increased levels of the viral
ORF54 transcript following a MHV68.DHS infection relative to
MHV68.WT or MHV68.MR (Figure S2). Thus, enhanced and/
or more rapid expression of lytic genes occurs in cells infected with
MHV68.DHS, perhaps escalating entry into the lytic cycle and
leading to larger plaques.
We also evaluated whether increased cell death might contribute
to the larger plaques observed following a MHV68.DHS infection.
We first measured necrosis by quantifying levels of lactate
dehydrogenase released into the media at 16 hpi, but detected no
measurable release following infection with any of the viruses (Figure
S3A). We next monitored apoptosis by several assays, including
measuring caspase activity, and testing for loss of plasma membrane
symmetry and increased membrane permeability. While there was a
slight, but statistically significant, increase in caspase 3/7 activity
following MHV68.DHS infection relative to MHV68.WT or
MHV68.MR infection, in all three cases the level was below that
observed in mock infected cells (Figure S3B), making it unlikely that
this is a primary cause of the increased plaque size. Plasma
membrane asymmetry wasmonitored using PE-conjugated Annexin
V, which binds to a component of the plasma membrane normally
found on the cytoplasmic surface, and membrane permeability was
quantified by the nucleotide binding dye 7-Amino-Actinomycin (7-
AAD). By flow cytometry we detected no significant increase in
AnnexinV bindingor7-AADstainingfollowinginfectionwitheither
MHV68.DHS or MHV8.MR relative to the uninfected control
(Figure S3C). Collectively, these findings indicate that although a
higher percentage of MHV68.DHS infected cells express viral lytic
antigens, this does not appear to cause enhanced cell death, nor does
it culminate in higher viral titers.
Host Shutoff is Dispensable for Acute Replication in vivo
The presumed natural route of MHV68 infection is through the
upper respiratory tract [30], whereupon the virus undergoes lytic
replication in the mucosal epithelial cells lining the mouse lung
and nasal cavity. Following intranasal inoculation, viral loads in
the lung peak 5–8 dpi before subsiding as the virus traffics to the
draining lymph nodes and ultimately to the spleen [31]. A burst of
lytic replication occurs in these sites of latency establishment
Figure 3. MHV68.DHS is defective for host shutoff. RNA was
isolated from NIH 3T3 cells infected with MHV68.WT, MHV68.DHS, or
MHV68.MR at an MOI of 10 at 20 h post infection. ActB (A), Rplp2 (B),
Tubb5 (C), GAPDH (D) and 18S RNA levels were quantified via RT-qPCR.
The mean and standard deviation of the normalized mRNA/18S ratio is
plotted for at least four independent experiments. The p-values
comparing MHV68.DHS and MHV68.MR are indicated. (E) COS7 cells
were infected with MHV68.WT or MHV68.DHS for 24 h. Both viruses
express GFP from the BAC vector sequence, which serves as a marker
for infection. PABPC localization was monitored by immunofluores-
cence with anti-PABPC antibodies, and cells were stained with DAPI to
visualize nuclei.
doi:10.1371/journal.ppat.1002150.g003
Figure 4. MHV68.DHS replicates with wild-type kinetics. Viral
replication kinetics were determined by multi-step growth curves in
mouse fibroblasts cells following an infection at a MOI of 0.1 with
MHV68.WT, MHV68.DHS, or MHV68.MR. At the indicated times post
infection virus was harvested, and the titer was determined by plaque
assay. The mean and standard deviation from at least three
independent experiments is graphed.
doi:10.1371/journal.ppat.1002150.g004
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center B cells, although also in macrophages and dendritic cells
[33]. By 14–18 dpi splenomegaly develops, and as many as one
out of 100 splenocytes harbor the latent viral genome [34].
Host shutoff manifests with delayed early kinetics during lytic
replication, consistent with the onset of muSOX expression [16].
We therefore hypothesized that MHV68.DHS would be attenu-
ated during lytic viral replication in the lung. We infected C57BL/
6 mice intranasally with 5610
4 pfu of MHV68.WT,
MHV68.DHS, or MHV68.MR, and monitored viral titers in the
lung at 3, 5, and 7 dpi by plaque assay. Viral titers were equivalent
at 3 dpi for all three viruses, and at 5 and 7 dpi we observed only a
very modest 2–3 fold defect in MHV68.DHS relative to
MHV68.MR accumulation (Figure 6). Although MHV68.WT
reached higher titers than MHV68.MR at 5 dpi, the two viruses
accumulated to equivalent levels at all earlier and later timepoints
(see subsequent sections). To ensure MHV68.DHS had not
reverted back to WT or incorporated any compensatory
mutations, we sequenced the muSOX gene from infected lung
homogenate but found no changes. Thus, contrary to our
hypothesis, host shutoff appears largely dispensable for acute
replication of gammaherpesviruses in vivo.
MHV68.DHS is Attenuated in Latency Establishment
To evaluate the role of host shutoff during later stages of the
viral lifecycle, mice were infected intranasally with 5610
4 pfu of
MHV68.WT, MHV68.DHS, or MHV68.MR, and the spleens
were harvested at 17 dpi, during the peak of latency establishment.
Interestingly, mice infected with MHV68.DHS did not display the
characteristic splenomegaly and had spleens three to four times
smaller than MHV68.WT and MHV68.MR infected mice
(Figure 7A), indicating a role for host shutoff in viral pathogenesis.
To evaluate the cause of MHV68.DHS attenuation, we first
performed an infectious center assay to test whether the
Figure 5. MHV68.DHS generates larger plaques and increases the percentage of lytic antigen-expressing cells. (A) Shown are
representative images of plaques generated 4 dpi in 3T3 cells infected with MHV68.DHS or MHV68.MR. The scale bar in the lower right corner of the
images represents 1 mm. (B) Plaque diameters of 75 plaques from 5 independent experiments were measured at 4 dpi from cells infected with
MHV68.DHS or MHV68.MR, and the frequency distribution was graphed. (C) 3T3 cells infected at an MOI of 1 with either MHV68-YFP or MHV68-
YFP.DHS were analyzed at 18 hpi for YFP and muSOX expression by immunofluorescence using anti-muSOX antibodies. Samples were co-stained
with DAPI to visualize nuclei. Shown are representative images from four independent experiments. The numbers of lytically infected cells (YFP- and
muSOX-positive) were determined by counting multiple fields of view from four independent experiments, and the percentage of infected cells
expressing muSOX is shown.
doi:10.1371/journal.ppat.1002150.g005
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lytic reactivation. In this assay, equivalent numbers of splenocytes
from infected mice are overlayed onto cultured mouse fibroblasts.
Spontaneous lytic reactivation of the splenocytes leads to infection
of the fibroblasts, which can be quantified by counting the
resulting plaques [34]. Splenocytes from MHV68.DHS infected
mice reactivated at a significantly lower frequency than those from
MHV68.WT or MHV68.MR infections (Figure 7B). This
reactivation frequency was independently assessed in a subset of
the samples by a limiting dilution cytopathic effect assay, which
yielded identical results (data not shown). Plaque assays on spleen
homogenates confirmed that no preformed virus was present,
indicating that the virus detected in these experiments originated
from latently infected cells.
The reduction in lytic reactivation frequency could either be a
consequence of a decreased number of latently infected spleno-
cytes or, alternatively, a failure of latently infected cells to undergo
lytic reactivation. To distinguish these possibilities, we first
monitored viral DNA load in the spleens of infected mice using
a previously described qPCR assay for the glycoprotein B (gB)
gene [35] and found that MHV68.DHS infected splenocytes
harbor fewer viral genomes than splenocytes infected with
MHV68.WT or MHV68.MR (Figure 7C). We also analyzed the
frequency of splenocytes harboring the viral genome by limiting
dilution PCR. Briefly, serial dilutions of splenocytes were plated in
a 96 well plate and subjected to nested PCR for the viral ORF50
gene [36]. Spiked template controls confirmed that in this assay we
were achieving near single copy sensitivity for the viral genome,
with a very low rate of false positives (data not shown). While
approximately one out of 200 splenocytes latently harbor the
MHV68.WT or MHV68.MR genome, the frequency of
MHV68.DHS genome harboring splenocytes was less than one
out of 10,000 splenocytes (Figure 7D). Thus, while host shutoff
appears dispensable for acute replication in the lung, it plays an
important role in the downstream events leading to efficient
latency establishment in the spleen.
MHV68.DHS Exhibits Defects in Both Trafficking and
Latency Establishment
During the normal course of an infection, the virus traffics from
the site of lytic replication in the lung to the draining lymph nodes
and spleen where latency is established. We reasoned that the
decreased frequency of latently infected splenocytes during
MHV68.DHS infection could be a consequence of a defect in
trafficking, persistence at these sites, or a latency establishment
defect. We quantified levels of virus in the cervical lymph node at
10 dpi, an intermediate time point after peak virus replication in
the lung but before peak latency establishment in the spleen.
Following an intranasal inoculation, high levels of MHV68 have
been found in the cervical lymph node at this time point [30,32].
Interestingly, we detected significantly lower levels of
MHV68.DHS at this site relative to MHV68.MR (Figure 8A),
suggesting that muSOX-induced mRNA degradation contributes
to the ability of the virus to traffic to or persist at the sites of latency
establishment.
To determine whether this was the root cause of the defect in
latency establishment upon MHV68.DHS infection, we next
infected mice via the intraperitoneal route, which bypasses the
requirement for the virus to undergo acute replication and traffic
through the lymph before reaching the spleen [37]. At 19 dpi, we
found significantly less MHV68.DHS virus in the spleen relative to
MHV68.MR by qPCR (Figure 8B), indicating that a defect in viral
trafficking cannot fully account for the latency establishment defect
observed during an intranasal infection. Collectively, these data
indicate that muSOX-induced host shutoff plays important roles
both in the ability of MHV68 to traffic to the lymph nodes, as well
as establish latency in the spleen.
Discussion
All gammaherpesviruses studied to date block host gene
expression through widespread mRNA degradation, yet the
contribution of this function towards the viral lifecycle remained
unknown. Here we analyzed the impact of host shutoff both in
tissue culture and in vivo infections with the murine gammaher-
pesvirus MHV68, and we found this activity to be largely
dispensable for acute lytic replication yet critical for the
downstream viral accumulation in the lymph nodes and
subsequent establishment of latency in the spleen. These results
were unexpected given that MHV68-induced host shutoff is
executed by muSOX, a viral protein whose expression has only
been detected during the lytic cycle [38,39,40]. In addition, the
role for muSOX-induced mRNA turnover clearly diverges from
Figure 6. MHV68.DHS replicates to near MHV68.MR levels during the acute phase of infection in the mouse lung. C57BL/6 mice were
infected intranasally with 5610
4 pfu MHV68.WT, MHV68.DHS, or MHV68.MR. At 3, 5, or 7 dpi lungs were harvested and homogenized, and viral titers
were determined by plaque assay. Each point on the graph represents the viral titer from a single lung, and the bar indicates the mean titer for each
virus. The dotted line represents the limit of detection at 20 pfu/lung. The p-values comparing MHV68.DHS and MHV68.MR are indicated. ‘‘n.s.’’
indicates a p-value greater than 0.05.
doi:10.1371/journal.ppat.1002150.g006
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induces global mRNA degradation but plays a critical role during
acute replication in vivo [41,42,43]. The severe attenuation of
HSV-1 and HSV-2 vhs mutants is hypothesized to be a
consequence of ineffective immune evasion, as vhs blocks dendritic
cell activation and down-regulates the type I interferon response
[44,45,46]. In contrast, we find little difference between
MHV68.MR and MHV68.DHS during acute replication in mice,
suggesting that while alpha- and gammaherpesviruses block host
gene expression via analogous mechanisms, the functional
ramifications of this activity are distinct, and may relate to the
unique in vivo biology of each class of virus.
Modeling the muSOX three-dimensional structure from the
KSHV SOX or EBV BGLF5 crystal structure [21,47] indicates
that amino acid R443 is positioned on the outer surface, away
from the catalytic core where nucleic acids are presumably cleaved
(data not shown). Although SOX, BGLF5, and muSOX are
functionally homologous and likely induce mRNA degradation
through a similar mechanism, the identified amino acid mutations
that selectively remove host shutoff activity are not conserved, nor
are they positioned in the same three-dimensional region. Likely
these different mutations alter the local structure of each protein
thereby inhibiting or weakening the mRNA or co-factor
interactions which contribute to overall mRNA degradation. In
this regard, we anticipate that the residual host shutoff activity
observed upon infection with the MHV68.DHS virus is at least
partially due to incomplete inactivation of muSOX mRNA
turnover activity by the R443I mutation.
Host shutoff has been hypothesized to play a role in the
diversion of gene expression resources and machinery towards the
virus during lytic replication [16,48], as well as general immune
evasion through the down-regulation of immune stimulatory
factors [49]. Our failure to detect a significant replication defect
for MHV68.DHS during a multi-step growth curve in cultured
Figure 7. MHV68.DHS is attenuated for latency establishment. In two independent experiments, C57BL/6 mice were infected intranasally
with 5610
4 pfu MHV68.WT, MHV68.DHS, or MHV68.MR, and spleens were harvested at 17 dpi. (A) The weight of each spleen is plotted with the mean
weight for each virus variant indicated by the bar. (B) Spleen cells were harvested and analyzed for lytic reactivation frequency via infectious center
assay. The number of reactivating splenocytes per 10
7 cells is plotted with the mean for each virus indicated by the bar. The dashed line denotes the
limit of detection. (C) DNA was isolated from spleen cells and analyzed by qPCR for the viral glycoprotein B (gB, ORF8) gene and endogenous GAPDH.
The normalized gB/GAPDH ratio is plotted along with the mean and standard deviation for each viral infection. The p-values comparing MHV68.DHS
to MHV68.MR are indicated. (D) The frequency of latently infected cells was determined by limiting dilution-PCR. The percent of wells positive for PCR
product is plotted for each dilution. Each point represents the average and standard deviation of three or four mice. The dotted line at 63.2% is used
to calculate the frequency of genome harboring cells according to the Poisson distribution.
doi:10.1371/journal.ppat.1002150.g007
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reallocation is unlikely to be the primary role for muSOX-induced
mRNA depletion. Likewise, the similar viral titers in the lungs of
mice infected with MHV68.MR or MHV68.DHS argues against a
role for muSOX in the general suppression of host innate immune
responses Because MHV68.DHS still retains residual mRNA
degradation activity, it is possible that some degree of host shutoff
could be important for viral replication. However, the appearance
of significant defects in downstream viral events even with a partial
host shutoff defect further strengthens our conclusion that host
shutoff plays a vital role in the lifecycle and pathogenesis of
MHV68 in vivo.
The first major defect observed in an in vivo MHV68.DHS
infection is significantly lower levels of the virus in the lymph nodes
at 10 dpi. Following an intranasal infection, wild-type MHV68
undergoes lytic replication in the lung and upper respiratory track,
after which the virus drains to the lymph nodes and spleen where a
variety of cell types are infected, including macrophages, dendritic
cells, and B-cells [37,50,51,52]. A burst of lytic replication occurs
at these sites [30,32], after which replicating virus is cleared and
long-term latency is established. Lower levels of MHV68.DHS in
the lymph node could be caused by a cell-type specific role for
muSOX-dependent mRNA degradation in viral replication or
immune evasion during viral transport to, and maintenance in, the
lymphatic tissue. The observation that the EBV muSOX homolog
(BGLF5) down-regulates HLA class I molecules and CD8
+ T cell
recognition in cultured cells may support this model [25]. The
means by which the virus traffics to the sites of latency
establishment remain unclear, yet it is likely that latently infected
B cells carry the virus given that viremia is undetectable during an
infection, and latently infected B cells are present in the lung very
early after infection [37,53,54]. A failure of MHV68.DHS to
establish latency in these cells might also cause their selective
immune-based eradication and decreased accumulation in the
lymph nodes. Alternatively, muSOX could influence the ability of
the virus to reactivate from latency, as this process has been linked
to efficient latency establishment. Mutations in a number of genes
alter the frequency of lytic reactivation and lead to lower levels of
latency establishment following an intranasal infection, such as v-
cyclin (ORF72) [55], M1 [56], M2 [57,58], and LANA (ORF73)
[59,60], but unlike muSOX these genes are all expressed during
latency as well as during lytic replication [61]. Mutations in the
lytic ORF36 gene encoding a protein kinase also lead to defects in
latency establishment and reactivation [62,63], which have been
tracked to the requirement for ORF36 to inhibit the IRF-3
mediated type I interferon response [62] and its modification of
the DNA-damage response protein H2AX [63]. Experiments are
currently underway to examine MHV68.DHS replication, reac-
tivation, and latency establishment in specific cell types relevant to
in vivo infection.
The second major defect observed upon MHV68.DHS
infection is a marked reduction in the number of infected
splenocytes present during peak latency establishment relative to
mice infected with wild-type or mutant rescue viruses. This defect
could arise simply as a downstream consequence of the
aforementioned impairment in trafficking. However, significantly
reduced levels of viral DNA are detected in the spleen even after
an intraperitoneal infection, which bypasses the need for acute
replication in the lung and subsequent trafficking through the
lymph nodes [37]. Thus, MHV68.DHS appears defective in both
trafficking and latency establishment in the spleen. Such a
phenotype might occur if MHV68.DHS-infected cells preferen-
tially entered the lytic cycle, perhaps enabling more efficient
clearance by the immune system. This model is supported by our
observation that an increased percentage of cultured 3T3 cells
infected with MHV68.DHS express lytic markers relative to those
infected with MHV68.WT. However, if this represents enhanced
entry into the lytic cycle, there must be a downstream defect that
tempers subsequent viral output, as the host shutoff mutant virus
does not replicate to higher titers in 3T3 cells than the wild-type
virus. In this regard, host shutoff could be important for optimizing
the balance of host or viral proteins in an infected cell, as has been
reported in an EBV mutant lacking BGLF5, where altered levels
of proteins inhibited viral maturation and egress [64]. One
mechanism that could shift the balance of infection away from
latency is if muSOX down-regulates factors that inhibit latency
establishment; such negative regulators would then accumulate in
the presence of the R443I mutant, driving cells into lytic
replication. MuSOX activity may also be required for the virus
Figure 8. MHV68.DHS fails to traffic to the lymph system and
establish latency. (A) C57BL/6 mice were infected intranasally with
5610
4 pfu MHV68.WT, MHV68.DHS, or MHV68.MR, and cervical lymph
nodes were harvested at 10 dpi. DNA was isolated from the cells and
analyzed by qPCR for the viral glycoprotein B (gB, ORF8) gene and
endogenous GAPDH. The normalized gB/GAPDH ratio is plotted along
with the mean for each viral infection. (B) Mice were infected
intraperitoneally with 1610
3 pfu of each of the indicated viruses.
DNA was isolated and quantified as above and the normalized gB/
GAPDH ratio is plotted along with the mean for each viral infection.
Each point on the graph represents the ratio from a single mouse. Data
for each figure are compilations of two independent experiments and
the p-values are indicated.
doi:10.1371/journal.ppat.1002150.g008
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packaged into the viral particle in order to efficiently establish
latency in newly infected cells rather than enter the lytic cycle.
The large plaque phenotype observed with MHV68.DHS is
similar to what is observed following infection with MHV68
constitutively expressing (or over-expressing) the lytic transcription
factor RTA [65]. Also similar to MHV68.DHS, these viruses
replicate to near wild-type levels in the lung but establish latency at
lower levels in the spleen. The constitutive RTA-expressing viruses
have been found to efficiently traffic to the spleen but fail to be
maintained at this site [66]. This attenuation has been ascribed to
the viruses producing excessive amounts of the RTA-inducible
lytic genes, creating an intracellular environment favoring
immediate entry into the lytic cycle rather than entering latency.
Thus, during an infection, an important role for muSOX may be
to ensure that factors driving lytic replication are not overrepre-
sented. While it is tempting to speculate a connection between the
increased percentage of lytically infected 3T3 cells and the latency
establishment defect in vivo with MHV68.DHS, at present the
precise relationship between these observations remains unclear.
Given the broad effects of host shutoff, the mechanism of
MHV68.DHS attenuation is anticipated to deviate from the gene-
for-gene interactions associated with many virulence factors.
Further research in this area will uncover the likely means by
which host shutoff influences latency establishment, as well as
reveal novel connections between the lytic and latent stages of the
gammaherpesviruses lifecycle.
Materials and Methods
PCR Mutagenesis
A hemagglutinin (HA) tag was introduced at the 59 end of
muSOX by PCR using the primers 59-CGGAATTCATGGCT-
TACCCATACGATGTACCTGACTATGCGATGGAAG GG-
TCGATTATTC-39 and 59-ATAGTTTAGCGGCCGCTTA-
GGGGGTTATGGGTTTTCT-39. HA-muSOX was then cloned
into the EcoRI/NotI sites of pCDEF3 containing a T7 promoter
to generate pCDEF3-T7-HA-muSOX. MuSOX was randomly
mutagenized by PCR with the Genemorph kit (Strategene)
according to the manufacturer’s protocol using 35 ng of
pCDEF3-T7-HA-muSOX as template, the above primers, and
30 PCR cycles to generate a pool of random mutants. The
mutants were then cloned into the EcoRI/NotI sites of pCDEF3-
T7. R443I was generated by QuickChange (Stratagene) using the
primers 59-GCTCATCATCACTCCTGT TATAATTCCATC-
TACTGTGCTGC-39 and 59-GCAGCACAGTAGATGGAAT-
TATAACAG GAGTGATGATGAGC-39.
Cells, Transfections, and Viruses
HEK293T, COS7, NIH 3T3, NIH 3T12, and Vero cells were
maintained in Dulbecco’s modified Eagle’s medium (DMEM;
Invitrogen) supplemented with 10% fetal bovine serum (FBS,
Invitrogen). 293T cells were transfected with Effectene (Qiagen)
following the manufacturer’s protocol.
The green fluorescent protein (GFP)-expressing MHV68
bacterial artificial chromosome (BAC) infectious clone has been
described elsewhere (RcHV68A98.01 [28]), and mutants were
generated by allelic exchange as previously described [67]. To
generate the MHV68.DHS BAC, a targeting region consisting of
566 nt upstream and 568 nt downstream of the mutation site was
ligated into pGS284 between BglII and NotI restriction sites and
electroporated into the S17lpir strain of E. coli. The MHV68-YFP
BAC infectious clone was a generous gift from Dr. Samuel Speck
(Emory University) [29], and MHV68-YFP.DHS was generated
using the same methodology as MHV68.DHS. The targeting
vector for the mutant rescue BAC (MHV68.MR) was generated
by ligating the region around wild-type muSOX into pGS284.
Targeting vector-containing cells were cross-streaked with BAC-
containing GS500 cells and successful recombinants were
identified by colony PCR and subsequent digest with PsiI. BAC
DNA was isolated from positive clones using the Qiagen Large-
Construct kit (Qiagen). BAC variants were verified by restriction
digests with EcoRI and PsiI and sequencing of the region
surrounding the recombination site. BAC-derived MHV68 virus
was produced by transfecting 2 mg of BAC DNA into NIH 3T3
cells using SuperFect (Qiagen). Virus was then amplified in NIH
3T12 cells and titered by plaque assays on NIH 3T3 cells. Before
infecting mice, the loxP-flanked BAC vector sequence was
removed from the recombinant viruses by passaging the virus
over Vero cells expressing Cre recombinase (kindly provided by
Dr. Samuel Speck, Emory University) [59], and BAC removal was
confirmed by PCR analysis.
Immunofluorescence Assays
MuSOX expression and PABPC or HA-muSOX localization
were analyzed as described previously [16,23]. Briefly, NIH 3T3,
HEK293T, or COS7 cells were grown on coverslips, and infected
with MHV68 variants or transfected with HA-muSOX variants.
Cells were then stained with rabbit polyclonal anti-muSOX (1:25
dilution), mouse monoclonal anti-PABPC 10e10 (1:25 dilution)
(Santa Cruz Biotechnology), or mouse monoclonal anti-HA (1:500
dilution) (Abcam) and AlexaFluor 546- or 488-conjugated goat
anti-mouse or goat anti-rabbit secondary antibody (1:1500).
Coverslips were mounted in DAPI-containing Vectashield mount-
ing medium (Vector Labs) to stain cell nuclei.
For flow cytometry analysis, NIH 3T3 cells were infected with
the indicated virus and, 18 hpi, cells were washed with PBS and
harvested via trypsin digestion. Cells were fixed in a 4%
formaldehyde solution, permeabilized in 1% Triton X-100 and
0.1% sodium citrate in PBS, and incubated with anti-muSOX
antibodies at a 1:12.5 dilution in 1% Triton X-100, 0.5% Tween,
and 3% BSA in PBS. Stained cells were then washed in PBS and
incubated with goat anti-rabbit antibodies conjugated to PE-Cy5.5
(Invitrogen) at a dilution of 1:150. Data were collected on an
EPICS XL cytometer (Beckman-Coulter) and analyzed using
FlowJo software (Tree Star).
Western Blots and Northern Blots
For Western blotting, cell lysates were prepared in RIPA buffer
[50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 2 mM EDTA, 1%
Nonidet P-40 (vol/vol), 0.1% SDS (w/vol)] containing Protease
Inhibitor Cocktail (Roche) and quantified by Bradford assay (Bio-
Rad). Equivalent amounts of each sample were resolved by SDS-
PAGE, transferred to a PVDF membrane, and Western blotted
with anti-HA 12CA5 monoclonal antibodies (Invitrogen; 1:5,000)
and HRP-conjugated goat anti-mouse secondary antibodies
(Southern Biotechnology; 1:5,000).
For Northern blotting, total RNA was harvested using RNA-
BEE (Tel-Test) and resolved by agarose-formaldehyde gel
electrophoresis. RNAs were transferred to a 0.45 mm nylon
membrane and probed with
32P-labeled GFP DNA probes
generated using the Rediprime II random prime labeling system
(GE Healthcare).
DNase Assays
DNase activity of the muSOX variants was performed as
described previously [16]. Briefly, muSOX variants were in vitro
transcribed with the mMessage mMachine T7 Kit (Ambion) and
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al product was incubated with linear DNA at 37uC for the
indicated time period and then the DNA was phenol/chloroform
extracted, and resolved by agarose gel electrophoresis. One-sixth
each IVT reaction was also separated by SDS-PAGE. The gels
were then fixed, dried, and visualized by autoradiography to verify
equivalent protein expression.
Quantitative PCR
To quantify RNA, we isolated RNA from transfected cells using
RNA-Bee (Tel-Test) or the Zymo Mini RNA II Isolation Kit (Zymo
Research). Samples were treated with Turbo DNase (Ambion)
according to the manufacturer’s protocol to remove genomic DNA
contamination. To generate cDNA, RNA samples were reverse
transcribed using AMV RT (Promega) and an oligo dT or 18S-
specific primer. 18S rRNA or GAPDH mRNA levels were quantified
using TaqMan ribosomal RNA control reagents or TaqMan rodent
GAPDH control reagents (Applied Biosystems). Other endogen-
ous mRNA levels were quantified using Applied Biosystems Taq-
man Gene Expression Assays (actB-Mm01205647_g1, rplp2-
Mm03059047_gH, tubb5-Mm00495806_g1). To quantify viral
genomes, DNA was first isolated from spleen cells or cervical lymph
node cells by the Qiagen QIAamp DNA Mini Kit following the
manufacturer’s protocol. Viral DNA levels were then measured using
a previously described assay targeting the MHV68 ORF8 gene [35].
All qPCR reactions were performed with TaqMan Universal PCR
Master Mix.
Cell Death Assays
To measure levels of lactate dehydrogenase (LDH) released into
the media during an infection, NIH 3T3 cells were infected at an
MOI of 5 for 16.5 h. Infection supernatant (60 ml) was mixed with
60 ml LDH detection reagent in triplicate in a 96-well plate as
described previously [68]. Absorbance was read on an Elisa-reader
at 490 nm wavelength. To detect caspase activity, NIH 3T3 cells
were infected at an MOI of 5 for 24 h, whereupon caspase activity
was measured using the Caspase-Glo 3/7 Assay System (Promega)
following the manufacturer’s protocol. To monitor Annexin V-PE
and 7-AAD staining by flow cytometry, NIH 3T3 cells were
infected at an MOI of 10 for 18 h. Cells were then washed with
PBS and harvested via trypsin digestion. Infection supernatant,
PBS wash, and cells were combined and pelleted by centrifugation.
Cells were washed in PBS and then stained for Annexin V-PE (BD
Biosciences, Material # 556422) and 7-AAD (BD Biosciences,
Material # 559925) via the manufacturer’s protocol using 3 mlo f
each dye. Data were collected on an EPICS XL cytometer
(Beckman-Coulter) and analyzed using FlowJo software (Tree
Star).
In vivo Infections and Experiments
Female C57BL/6J mice were obtained from The Jackson
Laboratory (Bar Harbor, ME) and infected when 4–6 weeks old.
Mice were anesthetized with isoflourane and inoculated intrana-
sally with 5610
4 plaque forming units (pfu) in 20 ml DMEM
(Invitrogen). For intraperitoneal infections, 1610
3 pfu in 0.2 ml
PBS were injected into the peritoneal cavity of mice. Lungs were
harvested at 3, 5, or 7 dpi, homogenized with a tissue
homogenizer for 1 minute at 24,000 rpm in 10 ml DMEM with
10% FBS, 100 U of penicillin per ml, and 100 mg of streptomycin
per ml (Pen/Strep, Invitrogen). Spleens were harvested at 17 or
19 dpi. To identify any preformed infectious particles, half of each
spleen was homogenized as above in 5 ml DMEM with 10% FBS,
and Pen/Strep. The tissue homogenate was then assayed for viral
particles by plaque assay on monolayers of NIH 3T3 cells overlaid
with 1% agarose for 4 days. The cells were then fixed and stained
with 0.04% methylene blue. Splenocytes were isolated from the
other half of the spleen by dissociating the spleen and passing
through a 40 mm cell strainer (BD-Falcon). Cells were then
pelleted, resuspended in red blood cell lysis buffer (150 mM
NH4Cl, 10 mM KHCO3, 0.1 mM EDTA), and incubated at
room temperature for 5 minutes. Cells were again pelleted and
resuspended in RPMI medium with 10%FBS and Pen/Strep
before counting. Cervical lymph nodes were harvested at 10 dpi
and isolated in the same manner as splenocytes, but without lysing
the red blood cells.
Infectious Center Assay
The number of reactivating splenocytes was determined as
described previously [34]. Briefly, 21,000 NIH 3T3 cells were
plated per well in a 24-well plate the day before infection.
2.5610
6,5 610
5,o r1 610
5 splenocytes were overlayed onto the
NIH 3T3 cells and incubated for 4 days. Cells were then fixed with
10% formaldehyde and stained with 0.04% methylene blue to
visualize plaques.
Limiting Dilution PCR
The frequency with which cells latently harbor the viral genome
was determined as described previously [36]. Briefly, 4-fold serial
dilutions of splenocytes were plated in 96-well plates with 16 wells
per dilution. Nested PCR for the ORF50 gene was performed and
the resulting PCR product was run on an agarose gel. Wells
positive for a PCR product by ethidium bromide staining contain
at least one copy of the viral genome. Single-copy sensitivity was
confirmed using serial dilutions of MHV68 BAC DNA.
Graph Design and Statistical Analysis
All graphs were designed and statistical analysis performed
using the GraphPad Prism Software version 4 or 5. Data were
analyzed for statistical significance using the Student’s t-test or, for
in vivo data, the Mann-Whitney nonparametric test. For limiting
dilution PCR analysis, data were subject to nonlinear regression
using the log(agonist) vs. response curve with a nonvariable slope.
Ethics Statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. The
protocol was approved by the Committee on the Ethics of Animal
Experiments of the University of California Berkeley (Permit
Number: R292-0507). All animals were anesthetized prior to
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Supporting Information
Figure S1 Levels of muSOX expressing cells increase
upon MHV68.DHS infections. 3T3 cells infected at an MOI
of 1 with either MHV68-YFP or MHV68-YFP.DHS were
analyzed at 18 hpi for YFP and muSOX expression by flow
cytometry using anti-muSOX antibodies. The percentage of cells
within each quadrant is indicated. Shown is a representative graph
of four independent experiments.
(EPS)
Figure S2 ORF54 transcript accumulates to higher
levels during a MHV68.DHS infection. 3T3 cells were
infected at an MOI of 5 with MHV68.WT, MHV68.DHS, or
MHV68.MR. At the indicated times post infection total RNA was
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quantified by RT-qPCR. Shown are the ORF54/18S ratios
normalized to wild-type infection at 18 hpi along with the mean
and standard deviation from at least five independent experiments.
The p-values comparing MHV68.DHS to MHV68.MR are
indicated. ‘‘n.s.’’ indicates that the p-value is greater than 0.05.
(EPS)
Figure S3 MHV68.DHS does not induce cell death. (A)
3T3 cells were infected for 16.5 h with MHV68.WT,
MHV68.DHS, or MHV68.MR at an MOI of 5, whereupon
levels of lactate dehydrogenase released into the media were
quantified by an enzymatic color change assay. Triton X-100 was
added at 1% to lyse cells as a positive control. Shown are the mean
and standard deviation from three experiments. (B) 3T3 cells were
infected as described above but for 24 h, then levels of caspase3/7
activity were quantified via a luciferase-based luminescent assay.
Etoposide (ETP) was included at 25 mM as a positive control.
Shown is the luciferase signal strength normalized to the mock
infected control along with the mean and standard deviation from
three independent experiments. The p-value comparing
MHV68.DHS to MHV68.MR is indicated. ‘‘n.s.’’ indicates that
the p-value is greater than 0.05. (C) 3T3 cells were infected at an
MOI of 10 and analyzed for Annexin V-PE and 7-AAD staining
18 hpi by flow cytometry. ETP was included at 25 mMa sa
positive control. The percentage of cells within each quadrant is
indicated.
(EPS)
Table S1 Amino acid mutations introduced into mu-
SOX.
(PDF)
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